Real-time enrollment status for this congenital hyperinsulinism clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 12:01 AM UTC
| NCT Number | NCT04205604 |
| Recruiting Status | Recruiting |
| Condition | Congenital Hyperinsulinism |
| Phase | PHASE2 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Miguel Pampaloni |
| Last Updated on CT.gov | May 1, 2026 (May 1, 2026) |
As of July 17, 2026: Clinical trial NCT04205604 is currently recruiting participants. This phase2 study for congenital hyperinsulinism is actively seeking new participants at 1 location across the United States. The study is sponsored by Miguel Pampaloni. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04205604 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04205604 was last updated May 1, 2026 (May 1, 2026). HelloStudys verifies this status automatically.